Lynas Rare Earths Ltd 2020 AR2
The report outlines Lynas Corporation's operational and financial performance for the fiscal year ended June 30, 2020, highlighting its resilience during the COVID-19 pandemic. Despite temporary shutdowns in Malaysia and Western Australia, the company maintained positive operating cash flows and progressed key Lynas 2025 growth projects, including the Kalgoorlie Rare Earth Processing Facility. Notably, Lynas secured a three-year renewal of its Malaysian operating licence and was awarded a Gold medal CSR rating from EcoVadis, placing it in the top 5% of evaluated companies. The company also improved its safety performance, achieving a 12-month rolling lost time injury frequency rate of 0.8 per million hours worked.
Company: Lynas Rare Earths Ltd
Sector: Materials
Country: Australia
Year: 2020
Type: AR2
Pages: 110
Back to company
Lynas Rare Earths Ltd
Annual Report
The report outlines Lynas Corporation's operational and financial performance for the fiscal year ended June 30, 2020, highlighting its resilience during the COVID-19 pandemic. Despite temporary shutdowns in Malaysia and Western Australia, the company maintained positive operating cash flows and progressed key Lynas 2025 growth projects, including the Kalgoorlie Rare Earth Processing Facility. Notably, Lynas secured a three-year renewal of its Malaysian operating licence and was awarded a Gold medal CSR rating from EcoVadis, placing it in the top 5% of evaluated companies. The company also improved its safety performance, achieving a 12-month rolling lost time injury frequency rate of 0.8 per million hours worked.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jul 1, 2019 - Jun 30, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management